Voloridge Investment Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.47M | Buy |
325,512
+109,510
| +51% | +$2.51M | 0.03% | 637 |
|
|
2025
Q1 | $6.26M | Buy |
216,002
+72,566
| +51% | +$2.1M | 0.02% | 718 |
|
|
2024
Q4 | $5.33M | Buy |
143,436
+19,991
| +16% | +$742K | 0.02% | 761 |
|
|
2024
Q3 | $5.99M | Sell |
123,445
-78,028
| -39% | -$3.79M | 0.02% | 736 |
|
|
2024
Q2 | $8.06M | Sell |
201,473
-20,327
| -9% | -$813K | 0.03% | 625 |
|
|
2024
Q1 | $9.74M | Sell |
221,800
-6,869
| -3% | -$302K | 0.04% | 497 |
|
|
2023
Q4 | $14.1M | Sell |
228,669
-142,641
| -38% | -$8.82M | 0.06% | 390 |
|
|
2023
Q3 | $17.1M | Buy |
371,310
+183,371
| +98% | +$8.43M | 0.08% | 317 |
|
|
2023
Q2 | $10.8M | Buy |
187,939
+114,995
| +158% | +$6.61M | 0.05% | 443 |
|
|
2023
Q1 | $2.74M | Sell |
72,944
-21,677
| -23% | -$813K | 0.01% | 889 |
|
|
2022
Q4 | $2.65M | Sell |
94,621
-67,637
| -42% | -$1.9M | 0.01% | 895 |
|
|
2022
Q3 | $4.56M | Sell |
162,258
-14,724
| -8% | -$414K | 0.02% | 681 |
|
|
2022
Q2 | $6.16M | Buy |
176,982
+82,912
| +88% | +$2.88M | 0.03% | 600 |
|
|
2022
Q1 | $3.38M | Buy |
+94,070
| New | +$3.38M | 0.02% | 783 |
|
|
2020
Q4 | – | Sell |
-45,541
| Closed | -$854K | – | 1302 |
|
|
2020
Q3 | $854K | Buy |
+45,541
| New | +$854K | 0.01% | 981 |
|